CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Introducing Dr. Alicia Zhou: A New Chapter in Leadership at the Cancer Research Institute

    The Cancer Research Institute (CRI) is excited to announce a transformative moment in its history with the…
    September 9, 2024| CRI Staff
  • Sarcoma Awareness Month: Tackling Chordoma with Dr. Cassian Yee

    CRI-Chordoma Foundation CLIP Investigator Dr. Cassian Yee is exploring how to design cell therapies for patients with…

    July 1, 2021| Arthur N. Brodsky, PhD
  • CRI Speaks with 2021 Lloyd J. Old Award Recipient Dr. Ton Schumacher

    Dr. Ton Schumacher, 2021 Lloyd J. Old Award recipient, discusses his career accomplishments and the future of…

    April 9, 2021| Arthur N. Brodsky, PhD
  • What to Expect in Cancer Immunotherapy in 2021: COVID-19, Biomarkers, and Clinical Trial Design

    Dr. Kunle Odunsi shares his thoughts on what lies ahead for the field of cancer immunotherapy.

    April 6, 2021| Arthur N. Brodsky, PhD
  • Las mujeres que erigieron el CRI y promovieron la inmunoterapia como tratamiento del cáncer

    CRI highlights some of the many women who are and have been integral to our organization and…

    March 24, 2021| Arthur N. Brodsky, PhD
  • CRI Scientific Leadership in Cancer and COVID-19

    Members of the CRI Scientific Advisory Council are providing their immunology expertise and sharing lessons from cancer…

    August 28, 2020| Alice Northover
  • Dr. Robert Schreiber and Interferon Gamma

    By redefining our understanding of the relationship between cancer and the immune system, Dr. Robert Schreiber has…

    May 16, 2019| Arthur N. Brodsky, PhD
  • Dr. James P. Allison, CRI Scientific Director, Awarded 2018 Nobel Prize along with Dr. Tasuku Honjo

    Dr. Allison’s discoveries and determination led to the development of the first FDA-approved checkpoint immunotherapy

    October 1, 2018| Arthur N. Brodsky, PhD
  • Previewing the 2018 Rational Combinations 360 Conference

    The third installment of the Rational Combinations 360 conference, which will be held in Philadelphia September 13-14,…

    September 10, 2018| Arthur N. Brodsky, PhD
1 2
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute